Matsubara Takao, Kusuzaki Katsuyuki, Matsumine Akihiko, Shintani Ken, Satonaka Haruhiko, Uchida Atsumasa
Department of Orthopedic Surgery, Mie University Faculty of Medicine, Mie, Japan.
Anticancer Res. 2006 Jan-Feb;26(1A):187-93.
Intra-operative photodynamic therapy has been applied with acridine orange (AO-PDT) to human musculoskeletal sarcomas for the past 4 years, resulting in a low local recurrence rate, within 10%, after intra-marginal tumor resection and excellent limb function. However, it is still unclear why acridine orange (AO) specifically accumulates in tumor cells, especially in malignant tumor cells. The purpose of this study was to clarify the mechanism of AO accumulation in malignant musculoskeletal tumors.
Sixty-two musculoskeletal tumors, including 35 malignant and 27 benign tumors, were studied. Using freshly resected tumor material, the extracellular pH (pHe) was measured and the fluorescence intensity of AO accumulated in the tumors was measured by an image analyzer after ex vivo exposure to 1.0 microg/ml AO, followed by blue excitation. In the in vitro study, bafilomycin A1 was exposed to LM 8 mouse osteosarcoma cells, in order to inhibit V-ATPase, subsequently causing a decrease in the pHgradient (deltapH) between the intracellular pH (pHi) and extracellular pH (pHe) or between the pHi and the pHe. AO accumulation and the cytocidal effect of AO were evaluated.
The results of the in vivo study, using human materials freshly resected at surgery, revealed that the pHe of the malignant musculoskeletal tumors was significantly lower than that of the benign tumors and normal muscles or adipose tissues and also showed that the AO fluorescence intensity of the malignant musculoskeletal tumors was significantly stronger than that of the benign tumors and normal muscles or adipose tissues. The results also revealed that the AO fluorescence intensity negatively correlated with the pHe in tumors and normal tissues. The in vitro study showed that bafilomycin A1 inhibited the accumulation of AO in acidic organelles, such as lysosomes, and that the cytocidal effect of AO-PDT was also remarkably inhibited.
Based on results of the in vivo and in vitro studies, it is suggested that malignant musculoskeletal tumors have a large deltapH between the pHi and the pHe or between the pHi and the vaculolar pH and also that a large ApH increases AO accumulation in tumors. We, therefore, believe that AO-PDT may be more effective in highly malignant musculoskeletal tumors than low grade ones, because of their acidity.
AO accumulation in musculoskeletal tumors was dependent on the ApH between the pHi and the pHe, or between the pHi and the vacuolar pH.
在过去4年中,术中光动力疗法已将吖啶橙(AO-PDT)应用于人类肌肉骨骼肉瘤,在肿瘤边缘内切除术后局部复发率较低,在10%以内,且肢体功能良好。然而,目前仍不清楚为什么吖啶橙(AO)会特异性地在肿瘤细胞中积累,尤其是在恶性肿瘤细胞中。本研究的目的是阐明AO在恶性肌肉骨骼肿瘤中积累的机制。
研究了62例肌肉骨骼肿瘤,包括35例恶性肿瘤和27例良性肿瘤。使用新鲜切除的肿瘤材料,测量细胞外pH值(pHe),并在体外暴露于1.0微克/毫升AO后,通过图像分析仪测量肿瘤中积累的AO的荧光强度,随后进行蓝光激发。在体外研究中,将巴弗洛霉素A1作用于LM 8小鼠骨肉瘤细胞,以抑制V-ATP酶,从而导致细胞内pH值(pHi)与细胞外pH值(pHe)之间或pHi与液泡pH值之间的pH梯度(ΔpH)降低。评估AO的积累和AO的杀细胞作用。
使用手术中新鲜切除的人体材料进行的体内研究结果表明,恶性肌肉骨骼肿瘤的pHe显著低于良性肿瘤、正常肌肉或脂肪组织,并且还表明恶性肌肉骨骼肿瘤的AO荧光强度显著强于良性肿瘤、正常肌肉或脂肪组织。结果还显示,肿瘤和正常组织中AO荧光强度与pHe呈负相关。体外研究表明,巴弗洛霉素A1抑制AO在酸性细胞器(如溶酶体)中的积累,并且AO-PDT的杀细胞作用也受到显著抑制。
基于体内和体外研究结果,提示恶性肌肉骨骼肿瘤在pHi与pHe之间或pHi与液泡pH之间存在较大的ΔpH,并且较大的ΔpH会增加AO在肿瘤中的积累。因此,我们认为AO-PDT在高度恶性的肌肉骨骼肿瘤中可能比低级别肿瘤更有效,因为它们具有酸性。
肌肉骨骼肿瘤中AO的积累取决于pHi与pHe之间或pHi与液泡pH之间的ΔpH。